MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.579
- -0.009-1.56%
Close Dec 24 13:00 ET
- 0.590
- +0.011+1.94%
Pre 08:00 ET
148.11MMarket Cap-3.47P/E (TTM)
0.590High0.575Low1.20MVolume0.581Open0.588Pre Close697.81KTurnover0.69%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High1.85P/B100.63MFloat Cap0.55152wk Low--Dividend TTM173.86MShs Float21.570Historical High--Div YieldTTM2.53%Amplitude0.420Historical Low0.582Avg Price1Lot Size
Adaptimmune Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 458.83%40.9M | 2,399.63%128.23M | -88.07%5.68M | 122.05%60.28M | -97.91%231K | 4.45%7.32M | -7.37%5.13M | 1,231.50%47.6M | 341.50%27.15M | 678.26%11.03M |
| Operating revenue | 458.83%40.9M | 2,399.63%128.23M | -88.07%5.68M | 122.05%60.28M | -97.91%231K | 4.45%7.32M | -7.37%5.13M | 1,231.50%47.6M | 341.50%27.15M | 678.26%11.03M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 3.02%55.58M | 18.97%59.53M | 24.18%54.94M | 5.03%198.32M | 39.23%50.09M | 7.91%53.95M | 1.52%50.04M | -17.39%44.24M | 12.13%188.82M | -18.76%35.97M |
| Selling and administrative expenses | 31.63%21.28M | -4.93%19.08M | 5.55%19.73M | 17.55%71.81M | 30.63%16.88M | -3.87%16.16M | 37.96%20.07M | 11.25%18.69M | 6.61%61.09M | -12.55%12.92M |
| -General and administrative expense | 31.63%21.28M | -4.93%19.08M | 5.55%19.73M | 17.55%71.81M | 30.63%16.88M | -3.87%16.16M | 37.96%20.07M | 11.25%18.69M | 6.61%61.09M | -12.55%12.92M |
| Research and development costs | -9.22%34.3M | 34.98%40.45M | 37.81%35.21M | -0.95%126.51M | 44.06%33.21M | 13.88%37.79M | -13.74%29.97M | -30.49%25.55M | 14.98%127.73M | -21.87%23.05M |
| Operating profit | 68.52%-14.68M | 252.98%68.7M | -1,566.54%-49.26M | 14.62%-138.04M | -99.86%-49.86M | -8.47%-46.63M | -2.64%-44.91M | 106.72%3.36M | 0.36%-161.67M | 41.80%-24.95M |
| Net non-operating interest income expense | -54.07%987K | -44.91%850K | 98.96%1.35M | 286.77%5.96M | 205.16%1.6M | 563.27%2.15M | 332.21%1.54M | 100.00%676K | 40.82%1.54M | 192.18%523K |
| Non-operating interest income | -2.47%2.1M | -10.82%1.38M | 98.96%1.35M | 286.77%5.96M | 205.16%1.6M | 563.27%2.15M | 332.21%1.54M | 100.00%676K | 40.82%1.54M | 192.18%523K |
| Non-operating interest expense | --1.11M | --526K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other net income (expense) | -619.30%-3.09M | -97.81%497K | 97.43%-61K | 789.69%19.54M | 91.84%-313K | -126.16%-430K | 3,558.93%22.66M | -19,883.33%-2.37M | -173.55%-2.83M | -195.00%-3.83M |
| Special income (charges) | --0 | --0 | --0 | 985.76%20.35M | --0 | ---106K | --22.16M | ---1.7M | ---2.3M | ---2.3M |
| -Less：Restructuring and merger&acquisition | --0 | --0 | --0 | -985.76%-20.35M | --0 | --106K | ---22.16M | --1.7M | --2.3M | --2.3M |
| Other non- operating income (expenses) | -854.63%-3.09M | -0.80%497K | 90.91%-61K | -50.56%-807K | 79.64%-313K | -119.71%-324K | 176.49%501K | -5,691.67%-671K | -113.91%-536K | -138.08%-1.54M |
| Income before tax | 62.63%-16.79M | 438.24%70.05M | -2,988.44%-47.98M | 30.94%-112.54M | -71.90%-48.57M | -9.49%-44.91M | 52.99%-20.71M | 103.35%1.66M | -3.60%-162.96M | 26.89%-28.26M |
| Income tax | 20.96%831K | -22.65%526K | -15.84%526K | -46.50%1.34M | -166.00%-656K | 72.18%687K | 44.68%680K | -1.42%625K | 215.68%2.5M | 375.60%994K |
| Net income | 61.37%-17.62M | 425.03%69.52M | -4,781.76%-48.5M | 31.18%-113.87M | -63.82%-47.92M | -10.09%-45.6M | 51.96%-21.39M | 102.06%1.04M | -4.66%-165.46M | 24.73%-29.25M |
| Net income continuous Operations | 61.37%-17.62M | 425.03%69.52M | -4,781.76%-48.5M | 31.18%-113.87M | -63.82%-47.92M | -10.09%-45.6M | 51.96%-21.39M | 102.06%1.04M | -4.66%-165.46M | 24.73%-29.25M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 61.37%-17.62M | 425.03%69.52M | -4,781.76%-48.5M | 31.18%-113.87M | -63.82%-47.92M | -10.09%-45.6M | 51.96%-21.39M | 102.06%1.04M | -4.66%-165.46M | 24.73%-29.25M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 61.37%-17.62M | 425.03%69.52M | -4,781.76%-48.5M | 31.18%-113.87M | -63.82%-47.92M | -10.09%-45.6M | 51.96%-21.39M | 102.06%1.04M | -4.66%-165.46M | 24.73%-29.25M |
| Basic earnings per share | 66.67%-0.06 | 350.00%0.3 | -2,970.81%-0.18 | 47.06%-0.54 | 0.00%-0.18 | 25.00%-0.18 | 60.00%-0.12 | 102.09%0.0063 | 0.00%-1.02 | 25.00%-0.18 |
| Diluted earnings per share | 66.67%-0.06 | 300.00%0.24 | -2,996.68%-0.18 | 47.06%-0.54 | 0.00%-0.18 | 25.00%-0.18 | 60.00%-0.12 | 102.07%0.0062 | 0.00%-1.02 | 25.00%-0.18 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
